To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Softgel Capsule Market size was valued at USD 7.62 billion in 2019 and is poised to grow from USD 7.67 billion in 2023 to USD 13.09 billion by 2031, growing at a CAGR of 7.9% in the forecast period (2024-2031).

The softgel capsule market is consolidated in nature. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective and customized solutions for students. 'Catalent Inc.', 'EuroCaps Ltd.', 'Aenova Group', 'Sirio Pharma Co., Ltd.', 'Captek Softgel International Inc.', 'NBTY, Inc.', 'Thermo Fisher Scientific Inc.', 'Robinson Pharma, Inc.', 'Gelita AG', 'Lonza Group Ltd.', 'Nature's Bounty, Inc.', 'Soft Gel Technologies, Inc.', 'Nutrilo GmbH', 'Weihai Baihe Biology Technological Co., Ltd.', 'Patheon N.V.', 'Roxlor, LLC', 'Vitaco Health Group', 'Procaps S.A.', 'Amway Corporation', 'Nutritional Holdings Pty Ltd.'

Growing Number of Clinical Trials Boosting Softgel Capsule Use to Promote Revenue Growth

A Persistent Trend is the Growing Demand for Plant-Based Capsules

North America held the highest share in the softgel capsule market. One of the main factors stimulating the expansion of the market in the area is the rising preference of major firms to launch products in developed North American nations. Key players aim for FDA and other regulatory body approvals to expand their client base abroad. The Europe softgel capsule market, on the other hand, generated a sizable amount of market revenue in 2021 owing to to the greater investment in the study and production of soft gelatin capsules across many European nations. During the forecast period, the softgel capsule market in Asia-Pacific is projected to expand at the highest CAGR due to much broader patient pool with a variety of chronic illnesses. Additionally, the regional expansion of key companies in the emerging economies of Asia-Pacific will boost its growth rate during the forecast period.

Feedback From Our Clients

Global softgel capsule market

Product ID: SQMIG35I2101

$5,300
BUY NOW